Pradaxa and Activated partial thromboplastin time prolonged - a phase IV clinical study of FDA data
Summary:
Activated partial thromboplastin time prolonged is reported as a side effect among people who take Pradaxa (dabigatran etexilate mesylate), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Lasix, and have Stroke.
The phase IV clinical study analyzes which people have Activated partial thromboplastin time prolonged when taking Pradaxa. It is created by eHealthMe based on reports of 86,033 people who have side effects when taking Pradaxa from the FDA, and is updated regularly.
What is Pradaxa?
Pradaxa has active ingredients of dabigatran etexilate mesylate. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 86,906 Pradaxa users. Check the latest studies of Pradaxa.
What is Activated partial thromboplastin time prolonged?
Activated partial thromboplastin time prolonged is found to be associated with 761 drugs and 1,211 conditions by eHealthMe. Check the latest studies of Activated partial thromboplastin time prolonged.
86,033 people reported to have side effects when taking Pradaxa.
Among them, 559 people (0.65%) have Activated partial thromboplastin time prolonged.
Among these 559 people:
How long have people been on Pradaxa when they have Activated partial thromboplastin time prolonged? *
What is the gender of people who have Activated partial thromboplastin time prolonged when taking Pradaxa? *
What is the age of people who have Activated partial thromboplastin time prolonged when taking Pradaxa? *
What are other drugs people take besides Pradaxa? *
What are other side effects people have besides Activated partial thromboplastin time prolonged? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Pradaxa and have Activated partial thromboplastin time prolonged?
- Check whether Activated partial thromboplastin time prolonged is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Pradaxa:
- Pradaxa (86,906 reports)
Activated partial thromboplastin time prolonged treatments and more:
- Activated partial thromboplastin time prolonged (8,799 reports)
How severe was Activated partial thromboplastin time prolonged and when was it recovered:
Expand to all the drugs that have ingredients of dabigatran etexilate mesylate:
- Activated partial thromboplastin time prolonged and drugs with ingredients of dabigatran etexilate mesylate (661 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Pradaxa:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Activated partial thromboplastin time prolonged:
- Activated partial thromboplastin time prolonged (761 drugs)
Browse all the conditions that are associated with Activated partial thromboplastin time prolonged:
- Activated partial thromboplastin time prolonged (1,211 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on dabigatran etexilate mesylate (the active ingredients of Pradaxa) and Pradaxa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Polyethylene Glycol 3350 and Acyclovir - 13 seconds ago
- Blood Potassium Decreased and drugs of ingredients of phenazopyridine hydrochloride - 15 seconds ago
- Topiramate vs. Maxalt, side effect and effectiveness comparison - 17 seconds ago
- Dexpanthenol and Acetaminophen drug interactions for boys aged 10-19 - 20 seconds ago
- Drug interactions of Entyvio and Albuterol - 41 seconds ago
- Topiramate vs. Sumatriptan Succinate, side effect and effectiveness comparison - 41 seconds ago
- Nephritis Allergic and drugs of ingredients of oxaliplatin - 43 seconds ago
- Could Octreotide Acetate cause Joint Swelling? - 55 seconds ago
- How effective is Saw Palmetto for Enlarged Prostate? - a minute ago
- How effective is Hytrin for Enlarged Prostate? - a minute ago